Development and Validation of the Pediatric Charcot–Marie–Tooth Disease Quality of Life Outcome Measure

Overview of attention for article published in Annals of Neurology, December 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)

Mentioned by

news: 1 news outlet

Readers on

mendeley: 58 Mendeley

So far, Altmetric has seen 1 news story.

Development and Validation of the Pediatric CMT Quality of Life Outcome Measure

MyNeuroNews, 22 Nov 2020

Objective Charcot‐Marie‐Tooth disease (CMT) reduces health‐related quality of life (QOL), especially in children.